Pages that link to "Q44339663"
Jump to navigation
Jump to search
The following pages link to A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function (Q44339663):
Displaying 50 items.
- The benefits and risks of testosterone replacement therapy: a review (Q24658011) (← links)
- THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study (Q26780084) (← links)
- The dominance behavioral system and psychopathology: evidence from self-report, observational, and biological studies (Q26824098) (← links)
- Testosterone treatment comes of age: new options for hypogonadal men (Q28258718) (← links)
- Patient satisfaction with testosterone replacement therapies: the reasons behind the choices (Q28304192) (← links)
- Improved Sexual Function with Testosterone Replacement Therapy in Hypogonadal Men: Real-World Data from the Testim Registry in the United States (TRiUS) (Q33990779) (← links)
- A practical guide to male hypogonadism in the primary care setting (Q34167760) (← links)
- Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men. (Q34560468) (← links)
- Transdermal testosterone delivery: testosterone patch and gel (Q35556846) (← links)
- Role of organ-sparing surgery in germ cell tumors of the testis (Q35694732) (← links)
- Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone (Q35840103) (← links)
- The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review (Q35855052) (← links)
- Androgen replacement therapy: present and future (Q35871132) (← links)
- Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats (Q38637128) (← links)
- Testosterone treatment for the aging man: the controversy (Q38637451) (← links)
- Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging (Q36130944) (← links)
- The effects of opioids on the endocrine system: an overview (Q36137885) (← links)
- Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). (Q36196710) (← links)
- Delivery options for contraceptives (Q36196835) (← links)
- Testosterone supplementation in the aging male: which questions have been answered? (Q36233399) (← links)
- Hypogonadism in the man with erectile dysfunction: what to look for and when to treat (Q36292445) (← links)
- Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery (Q36316846) (← links)
- Normative hypogonadism and depression: Does 'andropause' exist? (Q36361599) (← links)
- Review of Testim gel. (Q36407388) (← links)
- Benefits of a new testosterone gel formulation for hypogonadal men. (Q36465090) (← links)
- Emerging drugs for hypogonadism (Q36634275) (← links)
- Testosterone and body functions (Q36687889) (← links)
- Testosterone and the brain (Q36687897) (← links)
- Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available (Q36897412) (← links)
- The latest options and future agents for treating male hypogonadism (Q37000744) (← links)
- Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? (Q37194196) (← links)
- Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review (Q37218685) (← links)
- Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies (Q37307256) (← links)
- Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats (Q37426460) (← links)
- Safety and efficacy of testosterone gel in the treatment of male hypogonadism. (Q37448900) (← links)
- Androgens and erythropoiesis: past and present (Q37507425) (← links)
- Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. (Q37531098) (← links)
- The role of hypogonadism in Klinefelter syndrome. (Q37639188) (← links)
- A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. (Q37641683) (← links)
- Treating hypogonadism in younger males (Q37756140) (← links)
- The DSM Diagnostic Criteria for Hypoactive Sexual Desire Disorder in Men (Q37798575) (← links)
- Topical testosterone supplementation for the treatment of male hypogonadism (Q38032318) (← links)
- How to help the aging male? Current approaches to hypogonadism in primary care. (Q38052169) (← links)
- Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management (Q38572877) (← links)
- Body Composition changes with Testosterone Replacement Therapy following Spinal Cord Injury and Aging. A Mini Review. (Q38645004) (← links)
- Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive males (Q39351891) (← links)
- Timing of pubertal maturation and the onset of sexual behavior among Zimbabwe school boys (Q39732319) (← links)
- Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry (Q42286793) (← links)
- Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NFκB. (Q42368197) (← links)
- Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone (Q43176623) (← links)